4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with pancuronium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eglen, RM; Whiting, RL | 1 |
| Fehér, E; Matkó, I; Vizi, ES | 1 |
2 other study(ies) available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and pancuronium
| Article | Year |
|---|---|
Determination of the muscarinic receptor subtype mediating vasodilatation.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Atropine; Benzodiazepinones; Carbachol; Dogs; Female; Femoral Artery; Gallamine Triethiodide; In Vitro Techniques; Male; Pancuronium; Parasympatholytics; Phenethylamines; Piperidines; Pirenzepine; Rabbits; Receptors, Muscarinic; Vasodilation | 1985 |
Receptor mediated presynaptic modulation of the release of noradrenaline in human papillary muscle.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atropine; Berberine; Chromatography, High Pressure Liquid; Culture Techniques; Dopamine beta-Hydroxylase; Electric Stimulation; Feedback; Female; Heart Atria; Humans; Immunohistochemistry; Male; Middle Aged; Norepinephrine; Oxotremorine; Pancuronium; Papillary Muscles; Piperidines; Presynaptic Terminals; Receptors, Muscarinic; Sympathetic Nervous System; Tritium; Xylazine | 1994 |